A controlled trial of rifampicin, minocycline, and rifampicin plus minocycline for eradication of methicillin-resistant Staphylococcus aureus in long-term care patients

J Antimicrob Chemother. 1994 Jul;34(1):189-90. doi: 10.1093/jac/34.1.189.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Catheterization / adverse effects
  • Drug Therapy, Combination / therapeutic use*
  • Humans
  • Long-Term Care*
  • Methicillin Resistance*
  • Microbial Sensitivity Tests
  • Minocycline / therapeutic use*
  • Nasal Cavity / microbiology
  • Pilot Projects
  • Rifampin / therapeutic use*
  • Risk Factors
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / prevention & control*
  • Staphylococcal Infections / urine
  • Staphylococcus aureus / drug effects*

Substances

  • Minocycline
  • Rifampin